2020 Q4 Form 10-Q Financial Statement

#000156459020049431 Filed on November 02, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q4
Revenue $1.008B $804.0M $830.0M
YoY Change 21.45% 2.94% 3.88%
Cost Of Revenue $830.0M $657.0M $669.0M
YoY Change 24.07% 7.88% 6.7%
Gross Profit $174.0M $147.0M $161.0M
YoY Change 8.07% -14.53% -6.4%
Gross Profit Margin 17.26% 18.28% 19.4%
Selling, General & Admin $62.00M $98.00M $63.00M
YoY Change -1.59% 44.12% 0.0%
% of Gross Profit 35.63% 66.67% 39.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $26.00M $23.00M $18.00M
YoY Change 44.44% 15.0% -5.26%
% of Gross Profit 14.94% 15.65% 11.18%
Operating Expenses $63.00M $98.00M $49.00M
YoY Change 28.57% 44.12% -3.92%
Operating Profit $111.0M $49.00M $112.0M
YoY Change -0.89% -52.88% -7.44%
Interest Expense -$23.00M $20.00M -$16.00M
YoY Change 43.75% 11.11% 0.0%
% of Operating Profit -20.72% 40.82% -14.29%
Other Income/Expense, Net $31.00M -$1.000M -$6.000M
YoY Change -616.67% -125.0% 200.0%
Pretax Income $54.00M $10.00M $90.00M
YoY Change -40.0% -86.11% -12.62%
Income Tax $28.00M -$1.000M -$46.00M
% Of Pretax Income 51.85% -10.0% -51.11%
Net Earnings $26.00M $11.00M $136.0M
YoY Change -80.88% -71.05% 97.1%
Net Earnings / Revenue 2.58% 1.37% 16.39%
Basic Earnings Per Share $0.34 $0.15 $1.82
Diluted Earnings Per Share $0.34 $0.14 $1.79
COMMON SHARES
Basic Shares Outstanding 75.79M 75.74M shares 74.83M
Diluted Shares Outstanding 75.94M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $592.0M $312.0M $187.0M
YoY Change 216.58% 64.21% -4.59%
Cash & Equivalents $592.0M $312.0M $187.0M
Short-Term Investments
Other Short-Term Assets $110.0M $130.0M $85.00M
YoY Change 29.41% 120.34% 39.34%
Inventory $235.0M $237.0M $220.0M
Prepaid Expenses $62.00M $12.00M
Receivables $764.0M $642.0M $638.0M
Other Receivables $77.00M $68.00M $69.00M
Total Short-Term Assets $1.879B $1.392B $1.199B
YoY Change 56.71% 16.68% 1.7%
LONG-TERM ASSETS
Property, Plant & Equipment $505.0M $465.0M $471.0M
YoY Change 7.22% 8.14% 7.53%
Goodwill $193.0M $193.0M $193.0M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $30.00M $34.00M $36.00M
YoY Change -16.67% -17.07% -7.69%
Other Assets $135.0M $118.0M $108.0M
YoY Change 25.0% 9.26% 17.39%
Total Long-Term Assets $1.138B $1.075B $1.076B
YoY Change 5.76% 12.8% 13.86%
TOTAL ASSETS
Total Short-Term Assets $1.879B $1.392B $1.199B
Total Long-Term Assets $1.138B $1.075B $1.076B
Total Assets $3.017B $2.467B $2.275B
YoY Change 32.62% 14.96% 7.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.019B $461.0M $1.009B
YoY Change 0.99% -48.61% 10.15%
Accrued Expenses $242.0M $201.0M $310.0M
YoY Change -21.94% -45.08% -17.11%
Deferred Revenue $2.000M $1.000M $3.000M
YoY Change -33.33% 0.0% 50.0%
Short-Term Debt $570.0M $370.0M $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $4.000M
YoY Change -100.0% -100.0% -82.61%
Total Short-Term Liabilities $1.831B $1.032B $1.392B
YoY Change 31.54% -25.65% -3.33%
LONG-TERM LIABILITIES
Long-Term Debt $1.082B $1.045B $1.409B
YoY Change -23.21% -29.25% -10.2%
Other Long-Term Liabilities $120.0M $114.0M $274.0M
YoY Change -56.2% -52.1% 25.11%
Total Long-Term Liabilities $1.202B $1.159B $1.683B
YoY Change -28.58% -32.42% -5.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.831B $1.032B $1.392B
Total Long-Term Liabilities $1.202B $1.159B $1.683B
Total Liabilities $5.325B $4.663B $4.408B
YoY Change 20.8% 5.74% -5.02%
SHAREHOLDERS EQUITY
Retained Earnings -$2.207B -$2.233B -$2.282B
YoY Change -3.29% -10.47% -12.06%
Common Stock $28.00M $26.00M $19.00M
YoY Change 47.37% 36.84% 280.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.308B -$2.196B -$2.133B
YoY Change
Total Liabilities & Shareholders Equity $3.017B $2.467B $2.275B
YoY Change 32.62% 14.96% 7.11%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q4
OPERATING ACTIVITIES
Net Income $26.00M $11.00M $136.0M
YoY Change -80.88% -71.05% 97.1%
Depreciation, Depletion And Amortization $26.00M $23.00M $18.00M
YoY Change 44.44% 15.0% -5.26%
Cash From Operating Activities $161.0M -$41.00M $117.0M
YoY Change 37.61% -146.59% -12.03%
INVESTING ACTIVITIES
Capital Expenditures -$1.000M -$16.00M -$28.00M
YoY Change -96.43% -30.43% -3.45%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.000M $4.000M
YoY Change -100.0% -116.67% -200.0%
Cash From Investing Activities -$1.000M -$15.00M -$24.00M
YoY Change -95.83% -48.28% -27.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 190.0M 226.0M -101.0M
YoY Change -288.12% -602.22% -0.98%
NET CHANGE
Cash From Operating Activities 161.0M -41.00M 117.0M
Cash From Investing Activities -1.000M -15.00M -24.00M
Cash From Financing Activities 190.0M 226.0M -101.0M
Net Change In Cash 350.0M 170.0M -8.000M
YoY Change -4475.0% 1114.29% 300.0%
FREE CASH FLOW
Cash From Operating Activities $161.0M -$41.00M $117.0M
Capital Expenditures -$1.000M -$16.00M -$28.00M
Free Cash Flow $162.0M -$25.00M $145.0M
YoY Change 11.72% -122.52% -10.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1868000000
dei Document Quarterly Report
DocumentQuarterlyReport
true
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201613Member
CY2020Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2019Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2020Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2019Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2020Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2019Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2020Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2019Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M23D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3M18D
us-gaap Revenues
Revenues
2026000000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1648000000
CY2020Q3 us-gaap Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
0
us-gaap Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
0
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2000000
CY2020Q3 us-gaap Reorganization Items
ReorganizationItems
4000000
dei Entity Registrant Name
EntityRegistrantName
Garrett Motion Inc.
us-gaap Revenues
Revenues
2418000000
us-gaap Net Income Loss
NetIncomeLoss
177000000
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75788279
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38636
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-4873189
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Address Address Line1
EntityAddressAddressLine1
La Pièce 16
dei Entity Address City Or Town
EntityAddressCityOrTown
Rolle
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Address Country
EntityAddressCountry
CH
dei Entity Shell Company
EntityShellCompany
false
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
1180
dei City Area Code
CityAreaCode
41 21
dei Local Phone Number
LocalPhoneNumber
695 30 00
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-2046000000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4000000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
11000000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
215000000
us-gaap Gross Profit
GrossProfit
378000000
us-gaap Gross Profit
GrossProfit
550000000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-126000000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-22000000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-48000000
gtx Increase Decrease In Obligations Payable To Former Parent
IncreaseDecreaseInObligationsPayableToFormerParent
-84000000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
72000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
65000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
256000000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79000000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
38000000
us-gaap Net Income Loss
NetIncomeLoss
54000000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.37
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.34
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74753593
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75456358
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74528740
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75704457
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76123548
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75700652
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
11000000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
38000000
us-gaap Net Income Loss
NetIncomeLoss
54000000
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
102000000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-111000000
CY2020Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-6000000
CY2019Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
8000000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-8000000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-106000000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
110000000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-119000000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-95000000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
148000000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-65000000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
312000000
us-gaap Reorganization Items
ReorganizationItems
4000000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10000000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
11000000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75739152
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75943994
us-gaap Net Income Loss
NetIncomeLoss
177000000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1392000000
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1045000000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1409000000
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2000000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
51000000
CY2019Q4 gtx Obligations Payable To Former Parent Noncurrent
ObligationsPayableToFormerParentNoncurrent
1282000000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
274000000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-100000000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
127000000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1000000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
10000000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
138000000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
315000000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
187000000
CY2020Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
3000000
CY2020Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
710000000
CY2019Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
707000000
CY2020Q3 us-gaap Inventory Net
InventoryNet
237000000
CY2019Q4 us-gaap Inventory Net
InventoryNet
220000000
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
130000000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
85000000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
1392000000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1199000000
CY2020Q3 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
34000000
CY2019Q4 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
36000000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
465000000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
471000000
CY2020Q3 us-gaap Goodwill
Goodwill
193000000
CY2019Q4 us-gaap Goodwill
Goodwill
193000000
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
265000000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
268000000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
118000000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
108000000
CY2020Q3 us-gaap Assets
Assets
2467000000
CY2019Q4 us-gaap Assets
Assets
2275000000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
461000000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1009000000
CY2020Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
370000000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4000000
CY2019Q4 gtx Obligations Payable To Former Parent Current
ObligationsPayableToFormerParentCurrent
69000000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
201000000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
310000000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1032000000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
114000000
CY2020Q3 gtx Liabilities Not Subject To Compromise
LiabilitiesNotSubjectToCompromise
2193000000
CY2019Q4 gtx Liabilities Not Subject To Compromise
LiabilitiesNotSubjectToCompromise
4408000000
CY2020Q3 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
2470000000
CY2020Q3 us-gaap Liabilities
Liabilities
4663000000
CY2019Q4 us-gaap Liabilities
Liabilities
4408000000
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76202169
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74911139
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75788279
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74826329
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
26000000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19000000
CY2019Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
6000000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2000000
CY2019Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
4000000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2233000000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2282000000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
11000000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
130000000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-2196000000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-2133000000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2467000000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2275000000
us-gaap Profit Loss
ProfitLoss
54000000
us-gaap Profit Loss
ProfitLoss
177000000
us-gaap Reorganization Items
ReorganizationItems
4000000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-25000000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4000000
us-gaap Depreciation
Depreciation
60000000
us-gaap Depreciation
Depreciation
55000000
gtx Amortization Of Deferred Issuance Costs
AmortizationOfDeferredIssuanceCosts
5000000
gtx Amortization Of Deferred Issuance Costs
AmortizationOfDeferredIssuanceCosts
5000000
gtx Foreign Currency Transaction Gain Loss Excluding Hedges Before Tax
ForeignCurrencyTransactionGainLossExcludingHedgesBeforeTax
15000000
gtx Foreign Currency Transaction Gain Loss Excluding Hedges Before Tax
ForeignCurrencyTransactionGainLossExcludingHedgesBeforeTax
-32000000
us-gaap Share Based Compensation
ShareBasedCompensation
8000000
us-gaap Share Based Compensation
ShareBasedCompensation
14000000
us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
1000000
us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
4000000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-9000000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-7000000
gtx Increase Decrease In Accounts Notes And Other Receivables
IncreaseDecreaseInAccountsNotesAndOtherReceivables
35000000
gtx Increase Decrease In Accounts Notes And Other Receivables
IncreaseDecreaseInAccountsNotesAndOtherReceivables
29000000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
26000000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
33000000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
54000000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-7000000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
18000000
gtx Increase Decrease In Obligations Payable To Former Parent
IncreaseDecreaseInObligationsPayableToFormerParent
6000000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
20000000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4000000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-136000000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
125000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74000000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-12000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-79000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-62000000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
1449000000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
550000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
1100000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
550000000
gtx Repayments Of Senior Secured Debt And Term Loan
RepaymentsOfSeniorSecuredDebtAndTermLoan
2000000
gtx Repayments Of Senior Secured Debt And Term Loan
RepaymentsOfSeniorSecuredDebtAndTermLoan
62000000
gtx Payments For Debtor In Possession Financing Fees
PaymentsForDebtorInPossessionFinancingFees
4000000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
340000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-62000000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3000000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-7000000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
128000000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
79000000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
190000000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-2517000000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
73000000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
63000000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
66000000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
187000000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
196000000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
315000000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-2376000000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-2188000000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
38000000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
110000000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-35000000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4000000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-2341000000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-2133000000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
52000000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
39000000
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1000000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-9000000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-52000000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-2103000000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-106000000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2000000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-2196000000
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Note 1. Background and Basis of Presentation </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Background</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Garrett Motion Inc. (the “Company” or “Garrett”) designs, manufactures and sells highly engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (“OEMs”) and the global vehicle independent aftermarket, as well as automotive software solutions. These OEMs in turn ship to consumers globally. We are a global technology leader with significant expertise in delivering products across gasoline, diesel, natural gas and electric (hybrid and fuel cell) powertrains. These products are key enablers for fuel economy and emission standards compliance.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">COVID-19</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, a strain of novel coronavirus disease, COVID-19, was identified in Wuhan, China. This virus has been declared a pandemic and has spread across the world, including throughout Asia, the United States and Europe. Our business operations have been materially disrupted and our revenues have decreased significantly as a result of the COVID-19 pandemic and related response measures, and we expect our financial performance in the quarter ending December 31, 2020, and in future fiscal quarters, to be materially negatively affected by the pandemic and its impact on the global automotive industry.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:3.94%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">O<span style="color:#212529;">n June 12, 2020, the Company entered into an amendment (the “2020 Amendment”) to its Credit Agreement, dated as of September 27, 2018 (as amended, the “Credit Agreement”) by and among the Company, Garrett LX I S.à r.l., Garrett LX II S.à r.l., Garrett LX III S.à r.l., Garrett Borrowing LLC, and Garrett Motion Sàrl (f/k/a Honeywell Technologies Sàrl), the lenders and issuing banks party thereto and JPMorgan Chase Bank, N.A., as administrative agent, consisting of:</span></p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:3.94%;white-space:nowrap" valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td style="width:3.33%;white-space:nowrap" valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">•</span></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">a seven-year term B loan facility, consisting of a tranche denominated in Euro of €375 million and a tranche denominated in U.S. Dollars of $425 million (the “Term B Facility”);</span></p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:3.94%;white-space:nowrap" valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td style="width:3.33%;white-space:nowrap" valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">•</span></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">a five-year term A loan facility in an aggregate principal amount of €330 million (the “Term A Facility” and, together with the Term B Facility, the “Term Loan Facilities”); and</span></p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:3.94%;white-space:nowrap" valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td style="width:3.33%;white-space:nowrap" valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">•</span></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">a five-year revolving credit facility in an aggregate principal amount of €430 million (the “Revolving Facility” and, together with the Term Loan Facilities, the “Senior Credit Facilities”).</span></p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The primary purpose for entering into the 2020 Amendment was to obtain covenant relief with respect to the total leverage ratio and interest coverage ratios under the Credit Agreement as a result of the impact of the COVID-19 pandemic and the Company’s leveraged capital structure. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2020 Amendment qualified as a debt modification that did not result in an extinguishment or have a material impact on our Consolidated Interim Financial Statements.</p> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The commencement of the Chapter 11 Cases (as defined below) constituted an event of default that accelerated the Company’s obligations, as applicable, under the Credit Agreement. The Credit Agreement provides that as a result of the commencement of the Chapter 11 Cases, the principal, interest and all other amounts due thereunder shall be immediately due and payable. Any efforts to enforce the payment obligations under the Credit Agreement are automatically stayed as a result of the Chapter 11 Cases, and the creditors’ rights of enforcement in respect of the Credit Agreement are subject to the applicable provisions of the Bankruptcy Code.</p> <p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Voluntary Filing Under Chapter 11</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 20, 2020 (the “Petition Date”), the Company and certain of its subsidiaries (collectively, the “Debtors”) each filed a voluntary petition for relief under chapter 11 of title 11 of the United States Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the Southern District of New York (the “Bankruptcy Court”). The Debtors’ chapter 11 cases (the “Chapter 11 Cases”) are being jointly administered under the caption “In re: Garrett Motion Inc., 20-12212.”  On September 22 and 24, 2020, the Bankruptcy Court entered orders granting interim approval of certain forms of relief requested by the Debtors, enabling the Debtors to conduct their business activities in the ordinary course, subject to the terms and conditions of such orders, including authorizing the Debtors to pay employee wages and benefits, to pay taxes and certain governmental fees and charges, to continue to operate the Debtors’ cash management system in the ordinary course, to maintain certain customer programs, and to pay the prepetition claims of </p> <p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">certain of the Debtors’ vendors. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 20, 21 and 26, 2020, the Bankruptcy Court entered orders granting such relief on a final basis. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For goods and services provided following the Petition Date, the Debtors continue to pay vendors under normal terms.</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Consolidated Interim Financial Statements included herein have been prepared in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic No. 852, Reorganizations. See Note 2, Reorganization and Chapter 11 Proceedings, for further details.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Delisting from NYSE</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 20, 2020, the Company was notified by the New York Stock Exchange (the “NYSE”) that, as a result of the Chapter 11 Cases, and in accordance with Section 802.01D of the NYSE Listed Company Manual, that the NYSE had commenced proceedings to delist the Company’s common stock from the NYSE. The NYSE indefinitely suspended trading of the Company’s common stock on September 21, 2020. The Company determined not to appeal the NYSE’s determination. On October 8, 2020, the NYSE filed a Form 25-NSE with the Securities and Exchange Commission, which removed the Company’s common stock from listing and registration on the NYSE effective as of the opening of business on October 19, 2020.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Going Concern</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying Consolidated Interim Financial Statements have been prepared assuming that the Company will continue as a going concern and contemplate the realization of assets and the satisfaction of liabilities in the normal course of business. Liabilities subject to compromise will be resolved in connection with the Chapter 11 Cases. The Company’s ability to continue as a going concern is contingent upon the Company’s ability to successfully implement a plan of reorganization in the Chapter 11 Cases, among other factors. As a result of the Chapter 11 Cases, the realization of assets and the satisfaction of liabilities are subject to uncertainty. While operating as debtors-in-possession under the Bankruptcy Code, the Company may sell or otherwise dispose of or liquidate assets or settle liabilities, subject to the approval of the Bankruptcy Court or as otherwise permitted in the ordinary course of business, for amounts other than those reflected in the accompanying Consolidated Interim Financial Statements. Further, any plan of reorganization in the Chapter 11 Cases could materially change the amounts and classifications of assets and liabilities reported in the Consolidated Interim Financial Statements. The accompanying Consolidated Interim Financial Statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities or any other adjustments that might be necessary should the Company be unable to continue as a going concern or as a consequence of the Chapter 11 Cases. As a result of our financial condition, uncertainty related to the impacts of COVID-19, and the risks and uncertainties surrounding the Chapter 11 Cases, substantial doubt exists that we will be able to continue as a going concern.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">                  </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:6pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Basis of Presentation</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Consolidated Interim Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). All amounts presented are in millions, except per share amounts.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Asbestos-related expenses, net of probable insurance recoveries, are presented within Other expense, net in the Consolidated Interim Statement of Operations. Honeywell is subject to certain asbestos-related and environmental-related liabilities, primarily related to its legacy Bendix business. In conjunction with the Spin-Off, certain operations that were part of the Bendix business, along with the ownership of the Bendix trademark, as well as certain operations that were part of other legacy elements of the Business, were transferred to us. The accounting for the majority of our asbestos-related liability payments and accounts payable reflect the terms of the indemnification and reimbursement agreement with Honeywell entered into on September 12, 2018 (the “Subordinated Asbestos Indemnity Agreement”), under which Garrett ASASCO is required to make payments to Honeywell in amounts equal to 90% of Honeywell’s asbestos-related liability payments and accounts payable, primarily related to the Bendix business in the United States, as well as certain environmental-related liability payments and accounts payable and non-United States asbestos-related liability payments and accounts payable, in each case related to legacy elements of the Business, including the legal costs of defending and resolving such liabilities, less 90% of Honeywell’s net insurance receipts and, as may be applicable, certain other recoveries associated with such liabilities. The Subordinated Asbestos Indemnity Agreement provides that the agreement will terminate upon the earlier of (x) December 31, 2048 or (y) December 31st of the third consecutive year during which certain amounts owed to Honeywell during each such year were less than $25 million as converted into Euros in accordance with the terms of the agreement.  We are currently engaged in litigation against Honeywell in connection with the Subordinated Asbestos Indemnity Agreement. For additional information, see Note 18, Commitments and Contingencies.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases these estimates on assumptions that it believes to be reasonable under the circumstances, including considerations for the impact from the outbreak of the COVID-19 pandemic on the Company's business due to various global macroeconomic, operational and supply chain risks as a result of COVID-19. Actual results could differ from the original estimates, requiring adjustments to these balances in future periods. Furthermore, while operating as “debtors-in-possession” under Chapter 11, the Debtors may sell or otherwise dispose of or liquidate assets or settle liabilities, subject to the approval of the Bankruptcy Court or as otherwise permitted in the ordinary course of business and subject to </p> <p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">restrictions of the </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">debtor in possession (“DIP”)</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> financing, for amounts other than those reflected in the accompanying unaudited Consolidated </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interim </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial Statements. Any such actions occurring during the Chapter 11 Cases</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, including through a plan of reorganization</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> confirmed by the Bankruptcy Court could materially impact the amounts and classifications of assets and liabilities reported in the unaudited Consolidated Interim Financial Statements.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Consolidated Interim Financial Statements are unaudited; however, in the opinion of management, they contain all the adjustments (consisting of those of a normal recurring nature) considered necessary to state fairly the financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP applicable to interim periods. The Consolidated Interim Financial Statements should be read in conjunction with the audited annual Consolidated and Combined Financial Statements for the year ended December 31, 2019 included in our Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on February 27, 2020 (our “2019 Form 10-K”). The results of operations for the three and nine months ended September 30, 2020 and cash flows for the nine months ended September 30, 2020 should not necessarily be taken as indicative of the entire year.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We report our quarterly financial information using a calendar convention: the first, second and third quarters are consistently reported as ending on March 31, June 30 and September 30. It has been our practice to establish actual quarterly closing dates using a predetermined fiscal calendar, which requires our businesses to close their books on a Saturday in order to minimize the potentially disruptive effects of quarterly closing on our business processes. The effects of this practice are generally not significant to reported results for any quarter and only exist within a reporting year. For differences in actual closing dates that are material to year-over-year comparisons of quarterly or year-to-date results, such differences have been adjusted for the three months ended September 30, 2020. Our actual closing dates for the three months ended September 30, 2020 and 2019 were September 26, 2020 and September 28, 2019, respectively.<span style="font-size:12pt;"> </span></p>
gtx Restructuring Support Agreement Milestones Description
RestructuringSupportAgreementMilestonesDescription
The RSA provides certain milestones for the Restructuring Transactions. Failure of the Debtors to satisfy these milestones without a waiver or consensual amendment would provide the Requisite Consenting Lenders a termination right under the RSA. These milestones, as modified from time to time, include (a) no later than 5 days after the Petition Date, the Bankruptcy Court shall have entered the DIP Order (as defined below)on an interim basis, which DIP Order shall be in the form and substance acceptable to the Requisite Consenting Lenders; (b) no later than 35 days after the Petition Date, the Bankruptcy Court shall have entered (i) an order approving the bidding procedures with respect to the Acquisition and (ii) the DIP Order on a final basis; (c) no later than November 20, 2020, the Company Parties shall have filed an Acceptable Plan, Disclosure Statement, and a motion to approve the Disclosure Statement, each of which shall be in form and substance reasonably acceptable to the Requisite Consenting Lenders; (d) no later than January 8, 2021, (i) the hearing to approve the Disclosure Statement shall have occurred and (ii) the Bankruptcy Court shall have entered an order approving the Disclosure Statement on a final basis, which shall be in form and substance reasonably acceptable to the Requisite Consenting Lenders; (e) no later than 150 days after the Petition Date, a hearing shall have occurred for approval of (x) (i) the Acquisition and (ii) confirmation of the Plan or (y) another Acceptable Plan, and within 2 Business Days thereafter, the Bankruptcy Court shall have entered the Confirmation Order on a final basis, which shall be in form and substance reasonably acceptable to the Requisite Consenting Lenders; and (f) no later than 210 days after the Petition Date, (i) the Acquisition shall have closed and (ii) the Plan Effective Date shall have occurred.
us-gaap Debtor Reorganization Items Write Off Of Deferred Financing Costs And Debt Discounts
DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts
6000000
CY2019Q4 us-gaap Senior Notes
SeniorNotes
387000000
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
1822000000
CY2020Q3 us-gaap Debtor Reorganization Items Other Expense Income
DebtorReorganizationItemsOtherExpenseIncome
-2000000
us-gaap Debtor Reorganization Items Other Expense Income
DebtorReorganizationItemsOtherExpenseIncome
-2000000
CY2020Q3 us-gaap Debtor Reorganization Items Write Off Of Deferred Financing Costs And Debt Discounts
DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts
6000000
us-gaap Reorganization Items
ReorganizationItems
4000000
CY2020Q3 us-gaap Reorganization Items
ReorganizationItems
4000000
CY2020Q3 us-gaap Secured Debt
SecuredDebt
1415000000
CY2019Q4 us-gaap Secured Debt
SecuredDebt
1026000000
CY2020Q3 us-gaap Senior Notes
SeniorNotes
407000000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
1413000000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4000000
CY2020Q3 us-gaap Liabilities Subject To Compromise Debt And Accrued Interest
LiabilitiesSubjectToCompromiseDebtAndAccruedInterest
407000000
CY2020Q3 gtx Long Term Debt After Reclassified To Liabilities Subject To Compromise
LongTermDebtAfterReclassifiedToLiabilitiesSubjectToCompromise
1415000000
CY2019Q4 gtx Long Term Debt After Reclassified To Liabilities Subject To Compromise
LongTermDebtAfterReclassifiedToLiabilitiesSubjectToCompromise
1409000000
CY2020Q3 gtx Liabilities Subject To Compromise Obligations Payable To Former Parent
LiabilitiesSubjectToCompromiseObligationsPayableToFormerParent
1404000000
CY2020Q3 us-gaap Liabilities Subject To Compromise Debt And Accrued Interest
LiabilitiesSubjectToCompromiseDebtAndAccruedInterest
407000000
CY2020Q3 us-gaap Liabilities Subject To Compromise Accounts Payable And Accrued Liabilities
LiabilitiesSubjectToCompromiseAccountsPayableAndAccruedLiabilities
368000000
CY2020Q3 us-gaap Liabilities Subject To Compromise Pension And Other Postretirement Obligations
LiabilitiesSubjectToCompromisePensionAndOtherPostretirementObligations
94000000
CY2020Q3 gtx Liabilities Subject To Compromise Uncertain Tax Positions And Deferred Taxes
LiabilitiesSubjectToCompromiseUncertainTaxPositionsAndDeferredTaxes
62000000
CY2020Q3 gtx Liabilities Subject To Compromise Advanced Discounts From Suppliers
LiabilitiesSubjectToCompromiseAdvancedDiscountsFromSuppliers
34000000
CY2020Q3 gtx Liabilities Subject To Compromise Lease Liability
LiabilitiesSubjectToCompromiseLeaseLiability
19000000
CY2020Q3 gtx Liabilities Subject To Compromise Freight Accrual
LiabilitiesSubjectToCompromiseFreightAccrual
21000000
CY2020Q3 gtx Liabilities Subject To Compromise Product Warranties And Performance Guarantees
LiabilitiesSubjectToCompromiseProductWarrantiesAndPerformanceGuarantees
16000000
CY2020Q3 us-gaap Liabilities Subject To Compromise Other Liabilities
LiabilitiesSubjectToCompromiseOtherLiabilities
45000000
CY2020Q3 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
2470000000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
804000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2026000000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
781000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2418000000
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6000000
CY2020Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
48000000
us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
42000000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3000000
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1000000
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
2000000
CY2020Q3 gtx Indemnification Related Post Spin Off
IndemnificationRelatedPostSpinOff
14000000
CY2019Q3 gtx Indemnification Related Post Spin Off
IndemnificationRelatedPostSpinOff
18000000
gtx Indemnification Related Post Spin Off
IndemnificationRelatedPostSpinOff
41000000
gtx Indemnification Related Post Spin Off
IndemnificationRelatedPostSpinOff
54000000
gtx Indemnification Related Litigation
IndemnificationRelatedLitigation
3000000
gtx Factoring And Notes Receivables Discount Fees
FactoringAndNotesReceivablesDiscountFees
1000000
CY2020Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-14000000
CY2019Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-18000000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-45000000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-54000000
CY2020Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
48000000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79000000
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.100
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.472
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.169
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.309
CY2020Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
587000000
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
574000000
CY2020Q3 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
66000000
CY2019Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
68000000
CY2020Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
68000000
CY2019Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
69000000
CY2020Q3 gtx Accounts Notes And Other Receivables Gross
AccountsNotesAndOtherReceivablesGross
721000000
CY2019Q4 gtx Accounts Notes And Other Receivables Gross
AccountsNotesAndOtherReceivablesGross
711000000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
11000000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4000000
CY2020Q3 gtx Accounts Notes And Other Receivables Net
AccountsNotesAndOtherReceivablesNet
710000000
CY2019Q4 gtx Accounts Notes And Other Receivables Net
AccountsNotesAndOtherReceivablesNet
707000000
CY2020Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
48000000
us-gaap Accounts Receivable Sale
AccountsReceivableSale
128000000
CY2019 us-gaap Accounts Receivable Sale
AccountsReceivableSale
27000000
us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
51000000
CY2019 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
105000000
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
159000000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
142000000
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
20000000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
18000000
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
100000000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
85000000
CY2020Q3 us-gaap Inventory Gross
InventoryGross
279000000
CY2019Q4 us-gaap Inventory Gross
InventoryGross
245000000
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
42000000
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
25000000
CY2020Q3 us-gaap Inventory Net
InventoryNet
237000000
CY2019Q4 us-gaap Inventory Net
InventoryNet
220000000
CY2020Q3 gtx Advanced Discounts To Customers Non Current
AdvancedDiscountsToCustomersNonCurrent
67000000
CY2019Q4 gtx Advanced Discounts To Customers Non Current
AdvancedDiscountsToCustomersNonCurrent
62000000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
39000000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
35000000
CY2020Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
4000000
CY2020Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
8000000
CY2019Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
11000000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
118000000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
108000000
CY2020Q3 gtx Accrued Customer Pricing Reserve Current
AccruedCustomerPricingReserveCurrent
88000000
CY2019Q4 gtx Accrued Customer Pricing Reserve Current
AccruedCustomerPricingReserveCurrent
90000000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
51000000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
64000000
CY2020Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
2000000
CY2019Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
4000000
CY2020Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
13000000
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
29000000
CY2020Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
15000000
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
33000000
CY2020Q3 gtx Advanced Discounts From Suppliers Accrued Current
AdvancedDiscountsFromSuppliersAccruedCurrent
5000000
CY2019Q4 gtx Advanced Discounts From Suppliers Accrued Current
AdvancedDiscountsFromSuppliersAccruedCurrent
19000000
CY2020Q3 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
2000000
CY2019Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
12000000
CY2020Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1000000
CY2019Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
5000000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5000000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8000000
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
19000000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
46000000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
201000000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
310000000
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1000000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3000000
CY2018Q4 us-gaap Restructuring Reserve
RestructuringReserve
15000000
us-gaap Restructuring Charges
RestructuringCharges
3000000
us-gaap Payments For Restructuring
PaymentsForRestructuring
9000000
us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-5000000
CY2019Q3 us-gaap Restructuring Reserve
RestructuringReserve
4000000
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
4000000
us-gaap Restructuring Charges
RestructuringCharges
8000000
us-gaap Payments For Restructuring
PaymentsForRestructuring
6000000
gtx Restructuring Reserve Amounts Reclassified To Liabilities Subject To Compromise
RestructuringReserveAmountsReclassifiedToLiabilitiesSubjectToCompromise
-4000000
CY2020Q3 us-gaap Restructuring Reserve
RestructuringReserve
2000000
CY2020Q3 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
13000000
CY2019Q4 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
94000000
CY2020Q3 gtx Advanced Discounts From Suppliers Noncurrent
AdvancedDiscountsFromSuppliersNoncurrent
12000000
CY2019Q4 gtx Advanced Discounts From Suppliers Noncurrent
AdvancedDiscountsFromSuppliersNoncurrent
46000000
CY2020Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
42000000
CY2019Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
79000000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15000000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28000000
CY2020Q3 gtx Undesignated Cross Currency And Interest Rate Swaps
UndesignatedCrossCurrencyAndInterestRateSwaps
22000000
CY2019Q4 gtx Undesignated Cross Currency And Interest Rate Swaps
UndesignatedCrossCurrencyAndInterestRateSwaps
2000000
CY2020Q3 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
10000000
CY2019Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
25000000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
114000000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
274000000
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
some of which include options to extend the leases for up to two years
us-gaap Lessee Operating Lease Option To Terminate
LesseeOperatingLeaseOptionToTerminate
some of which include options to terminate the leases within the year
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
5000000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
4000000
us-gaap Operating Lease Cost
OperatingLeaseCost
11000000
us-gaap Operating Lease Cost
OperatingLeaseCost
10000000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
4000000
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
3000000
us-gaap Operating Lease Payments
OperatingLeasePayments
9000000
us-gaap Operating Lease Payments
OperatingLeasePayments
9000000
CY2020Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1000000
CY2019Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2000000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6000000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10000000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
39000000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
35000000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5000000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8000000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15000000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28000000
CY2020Q3 gtx Operating Lease Liabilities Subject To Compromise
OperatingLeaseLiabilitiesSubjectToCompromise
19000000
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0616
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0636
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75456358
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76123548
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4000000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
11000000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
9000000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6000000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5000000
CY2020Q3 gtx Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
11000000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
46000000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7000000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
39000000
CY2020Q3 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
373000000
CY2019Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
1820000000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
11000000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
38000000
us-gaap Net Income Loss
NetIncomeLoss
54000000
us-gaap Net Income Loss
NetIncomeLoss
177000000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75739152
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74753593
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75456358
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74528740
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.37
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
11000000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
38000000
us-gaap Net Income Loss
NetIncomeLoss
54000000
us-gaap Net Income Loss
NetIncomeLoss
177000000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75739152
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74753593
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74528740
CY2020Q3 gtx Incremental Common Shares Attributable To Unvested Restricted Stock Units And Other Contingently Issuable Shares
IncrementalCommonSharesAttributableToUnvestedRestrictedStockUnitsAndOtherContingentlyIssuableShares
204842
CY2019Q3 gtx Incremental Common Shares Attributable To Unvested Restricted Stock Units And Other Contingently Issuable Shares
IncrementalCommonSharesAttributableToUnvestedRestrictedStockUnitsAndOtherContingentlyIssuableShares
950864
gtx Incremental Common Shares Attributable To Unvested Restricted Stock Units And Other Contingently Issuable Shares
IncrementalCommonSharesAttributableToUnvestedRestrictedStockUnitsAndOtherContingentlyIssuableShares
667190
gtx Incremental Common Shares Attributable To Unvested Restricted Stock Units And Other Contingently Issuable Shares
IncrementalCommonSharesAttributableToUnvestedRestrictedStockUnitsAndOtherContingentlyIssuableShares
1171912
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75943994
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75704457
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75700652
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.34
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
425866
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
435021
CY2019 gtx Resolution Values Of Malignant Claims
ResolutionValuesOfMalignantClaims
50200
CY2018 gtx Resolution Values Of Malignant Claims
ResolutionValuesOfMalignantClaims
55300
CY2017 gtx Resolution Values Of Malignant Claims
ResolutionValuesOfMalignantClaims
56000
CY2016 gtx Resolution Values Of Malignant Claims
ResolutionValuesOfMalignantClaims
44000
CY2019 gtx Resolution Values Of Nonmalignant Claims
ResolutionValuesOfNonmalignantClaims
3900
CY2018 gtx Resolution Values Of Nonmalignant Claims
ResolutionValuesOfNonmalignantClaims
4700
CY2017 gtx Resolution Values Of Nonmalignant Claims
ResolutionValuesOfNonmalignantClaims
2800
CY2016 gtx Resolution Values Of Nonmalignant Claims
ResolutionValuesOfNonmalignantClaims
4485

Files In Submission

Name View Source Status
0001564590-20-049431-index-headers.html Edgar Link pending
0001564590-20-049431-index.html Edgar Link pending
0001564590-20-049431.txt Edgar Link pending
0001564590-20-049431-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ghvom3d4wwxy000001.jpg Edgar Link pending
ghvom3d4wwxy000002.jpg Edgar Link pending
gtx-10q_20200930.htm Edgar Link pending
gtx-10q_20200930_htm.xml Edgar Link completed
gtx-20200930.xsd Edgar Link pending
gtx-20200930_cal.xml Edgar Link unprocessable
gtx-20200930_def.xml Edgar Link unprocessable
gtx-20200930_lab.xml Edgar Link unprocessable
gtx-20200930_pre.xml Edgar Link unprocessable
gtx-ex311_9.htm Edgar Link pending
gtx-ex312_11.htm Edgar Link pending
gtx-ex321_10.htm Edgar Link pending
gtx-ex322_7.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending